CSG’s Rerating Hinges on Next Week’s Q1 Numbers as Multiple Headwinds Test Investor Patience
12.05.2026 - 19:12:08 | boerse-global.de
The Czech defence group CSG is living a tale of two realities. Revenues surged 72% last year to €6.7 billion and net profit hit €872 million, yet the stock trades at roughly €15.90 — more than half below its January peak and barely above the year’s low. That 53% rout has left the equity priced at a forward P/E of 15, a deep discount to the European defence sector average, despite nine out of nine analysts rating it a buy with an average target of €35.40.
The disconnect stems from a perfect storm of near?term uncertainties. The most time?sensitive issue is the EU’s SAFE financing programme, which offers loans at just 1% for defence contracts that involve at least two member states. CSG signed a seven?year framework agreement with Slovakia potentially worth €58 billion for ammunition deliveries, but that window of ultra?cheap funding slams shut at the end of May. So far, no second EU country has formally signed up. Romania’s defence ministry has denied any ministerial?level talks, while Croatia is still evaluating participation without committing. CSG has downplayed the risk, insisting the deal does not hinge on a single financing mechanism, but higher borrowing costs would inevitably dent the contract’s appeal for Bratislava.
The market’s second worry is the activist assault. Hunterbrook Capital publicly attacked CSG’s artillery production claims, alleging the company overstated its output of 600,000 units. CSG hit back, saying it actually produced around 630,000 large?calibre shells and that Hunterbrook misinterpreted the fragmented nature of its production across multiple sites. Another controversy — a €275 million related?party receivable — was resolved in the first quarter of 2026, fully settled in cash. But the short?seller’s narrative has left a mark, amplified by a separate dispute with a minority shareholder who is reportedly demanding €1.4 billion for his stake and holds blocking rights over a key subsidiary.
Should investors sell immediately? Or is it worth buying CSG?
Adding to the noise, the NATO Support and Procurement Agency has temporarily suspended CSG’s Spanish subsidiary, Fábrica de Municiones de Granada (FMG), from certain procurement procedures. CSG insists the exclusion is narrowly defined geographically and has no material impact on the group’s broader interests. The company says it is reviewing the allegations and reserves the right to take legal action against what it calls misleading analysis. On the credit side, Moody’s upgraded CSG’s secured debt to investment?grade Baa3 in February, a sign that rating agencies see the operational strength beneath the market turbulence.
Operationally, the trajectory remains upward. For 2026, management guides for revenue between €7.4 billion and €7.6 billion with an EBIT margin of 24%–25%. The group is expanding internal production capacity by a fifth by year?end, including a new large?calibre ammunition line in Slovakia designed to deepen vertical integration and reduce supply?chain risks. The artillery and ammunition segment already accounts for the bulk of group sales.
Investors will get their first hard data point since the silent period ended when CSG reports first?quarter results. Some sources indicate the release will be on 19 May, others on 20 May. The market will scrutinise whether those double?digit margins held and whether any of the recent contract wins are already feeding through. Hard on the heels of that report, the SAFE deadline looms at the end of May. A second participant would go a long way to restoring confidence in the Slovak framework — and in the stock’s battered valuation.
Ad
CSG Stock: New Analysis - 12 May
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis CSG’s Aktien ein!
FĂĽr. Immer. Kostenlos.
